Glycogen Storage Disease Type IIb
An X-linked dominant multisystem disorder resulting in cardiomyopathy, myopathy and INTELLECTUAL DISABILITY. It is caused by mutation in the gene encoding LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 2.
Year introduced: 2006
PubMed search builder options
Subheadings:
Tree Number(s): C10.597.606.360.455.562, C14.280.238.458, C16.320.322.201, C16.320.565.202.449.510, C18.452.648.202.449.510
MeSH Unique ID: D052120
Entry Terms:
- Danon Disease
- Vacuolar Cardiomyopathy and Myopathy, X-linked
- Vacuolar Cardiomyopathy and Myopathy, X linked
- Glycogen Storage Disease IIb
- X-Linked Vacuolar Cardiomyopathy and Myopathy
- X Linked Vacuolar Cardiomyopathy and Myopathy
- Pseudoglycogenosis 2
- Pseudoglycogenosis 2s
- Glycogen Storage Cardiomyopathy
- Cardiomyopathies, Glycogen Storage
- Cardiomyopathy, Glycogen Storage
- Glycogen Storage Cardiomyopathies
- Glycogen Storage Disease Type 2B
- Antopol Disease
- Disease, Antopol
- Lysosomal Glycogen Storage Disease with Normal Acid Maltase
- Glycogen Storage Disease Limited to the Heart
- Lysosomal Glycogen Storage Disease without Acid Maltase Deficiency
- Pseudoglycogenosis II
- Pseudoglycogenosis IIs